A new study published in Nanotechnology offers new hope for less harmful breast cancer therapy by combining two powerful, non ...

Elenagen™, a novel DNA plasmid therapy that previously demonstrated high clinical benefit and low toxicity in cancer patients, has now shown significant promise in alleviating chronic pain ...

Neoadjuvant immunotherapy is associated with high rates of event-free survival in patients with resectable melanoma.

Pfizer is positioning for a potential long-term rebound following a steep post-COVID revenue decline and a drop of over 50% ...

Panelists discuss how subcutaneous (SubQ) and intravenous (IV) oncology therapies will continue to coexist, with ...

Q2 2025 Earnings Call Transcript July 16, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.77, ...

Improvements in rural cancer care in Kentucky could be imperiled by President Trump's tax and domestic policy bill.

Emerging therapies, including antibody-drug conjugates and biomarker-driven approaches, have the potential to significantly ...

SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT. AND NEW NUMBER OF SHARES . Ghent, Belgium, 22 July 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Se ...

Identical twin brothers and entrepreneurs Dylan and Jake Pinksterboer have raised funds in a last-ditch effort to help their ...

A stage-four cancer diagnosis once sounded like the end of the road – after all, there is no stage five. When Joe Biden’s ...

Alex the Great, a beloved therapy rabbit that brought comfort to arenas and other major venues across the U.S., has died. He ...